Jade Biosciences (JBIO) Operating Leases (2021 - 2026)

Jade Biosciences (JBIO) reported Operating Leases of $700000.0 for Q1 2026, down 3.31% quarter-over-quarter from $724000.0 in Q4 2025.

Jade Biosciences (JBIO) Operating Leases (2021 - 2026) Analysis & Trends

Jade Biosciences has reported Operating Leases for 6 years, with the latest figure at $700000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Operating Leases changed N/A year-over-year to $700000.0; the trailing twelve-month figure through Mar 2026 stood at $700000.0 (changed N/A YoY), and the FY2025 full-year result was $724000.0, changed N/A from the prior year.
  • Operating Leases for Q1 2026 stood at $700000.0, down from $724000.0 in the prior quarter.
  • The five-year high for Operating Leases was $1.2 million in Q2 2022, with the low at $81000.0 in Q3 2024.
  • Historically, Operating Leases has averaged $566733.3 across 5 years, with a median of $591000.0 in 2023.
  • Annual changes were most pronounced in 2024 — Operating Leases slumped 77.37% — and 2025, when it jumped 822.22%.
  • Jade Biosciences' Operating Leases stood at $705000.0 in 2022, then tumbled by 63.83% to $255000.0 in 2023, then plunged by 68.24% to $81000.0 in 2024, then soared by 793.83% to $724000.0 in 2025, then dropped by 3.31% to $700000.0 in 2026.
  • The last three Operating Leases figures came in at $700000.0 (Q1 2026), $724000.0 (Q4 2025), and $747000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn -
7 Psyence Biomedical 229.39 Bn 229.38 Bn -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn
9 Abivax 90.15 Bn 90.15 Bn -
10 Jade Biosciences 877.06 Mn 877.06 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 700,000.00
Dec 31, 2025 724,000.00
Sep 30, 2025 747,000.00
Jun 30, 2025 792,000.00
Sep 30, 2024 81,000.00
Jun 30, 2024 206,000.00
Mar 31, 2024 329,000.00
Dec 31, 2023 255,000.00
Sep 30, 2023 358,000.00
Jun 30, 2023 476,000.00
Mar 31, 2023 591,000.00
Dec 31, 2022 705,000.00
Sep 30, 2022 800,000.00
Jun 30, 2022 1.21 Mn
Mar 31, 2022 528,000.00
Dec 31, 2021 382,000.00
Sep 30, 2021 452,000.00